Thursday, August 3, 2006 • Vol 12, Issue 15

Julie McElrath
Dr. Julie McElrath, Clinical Research Division, will receive $30.1 million to lead a consortium dedicated to testing the effectiveness of adjuvants — compounds which can enhance cellular immune responses and aid HIV-vaccine development.
Photo by Jim Linna

Science Articles
General Articles
Briefs

Credits


Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2008 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.